Ha habido 50 transacciones internas recientes registradas para AbbVie Inc. (ABBV), incluyendo 32 compras y 15 ventas. El total de compras internas fue valorado en $50.13M y el total de ventas internas en $39.84M.
Internos destacados con actividad reciente incluyen Rapp Edward J, Alpern Robert J, Quaggin Susan E. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ABBV
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-31 |
Rapp Edward J |
Director |
Concesión de RSU |
155 |
$217.49 |
$33.71K |
28,865 |
| 2026-03-31 |
Alpern Robert J |
Director |
Concesión de RSU |
35 |
$217.49 |
$7.61K |
10,369 |
| 2026-03-31 |
Quaggin Susan E |
Director |
Concesión de RSU |
71 |
$217.49 |
$15.44K |
784 |
| 2026-03-04 |
Purdue David Ryan |
SVP, Controller |
Venta Informativa |
5,230 |
$233.56 |
$1.22M |
2,654 |
| 2026-03-02 |
Siatis Perry C |
EVP, Gc and Secretary |
Venta Informativa |
2,600 |
$235.26 |
$611.68K |
4,619 |
| 2026-02-27 |
Saleki-gerhardt Azita |
EVP, Chief Operations Officer |
Retención Fiscal de RSU |
16,309 |
$232.08 |
$3.78M |
197,794 |
| 2026-02-27 |
Michael Robert A. |
Chairman of the Board and CEO |
Retención Fiscal de RSU |
36,523 |
$232.08 |
$8.48M |
178,737 |
| 2026-02-27 |
Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
Retención Fiscal de RSU |
23,812 |
$232.08 |
$5.53M |
83,171 |
| 2026-02-27 |
Donoghoe Nicholas |
EVP, Chief Bus/strat Officer |
Retención Fiscal de RSU |
12,874 |
$232.08 |
$2.99M |
74,430 |
| 2026-02-27 |
Reents Scott T |
EVP, Chief Financial Officer |
Retención Fiscal de RSU |
21,638 |
$232.08 |
$5.02M |
38,777 |
| 2026-02-27 |
Siatis Perry C |
EVP, Gc and Secretary |
Retención Fiscal de RSU |
14,850 |
$232.08 |
$3.45M |
23,287 |
| 2026-02-27 |
Thakkar Roopal |
EVP, R&d and CSO |
Retención Fiscal de RSU |
8,037 |
$232.08 |
$1.87M |
52,376 |
| 2026-02-27 |
Purdue David Ryan |
SVP, Controller |
Retención Fiscal de RSU |
2,692 |
$232.08 |
$624.76K |
7,884 |
| 2026-02-27 |
Crum Demetris D |
EVP, Chief HR Officer |
Retención Fiscal de RSU |
1,594 |
$232.08 |
$369.94K |
7,914 |
| 2026-02-27 |
Purdue David Ryan |
SVP, Controller |
Retención Fiscal de RSU |
2,108 |
$232.08 |
$489.22K |
8,468 |
| 2026-02-25 |
Siatis Perry C |
EVP, Gc and Secretary |
Ejercicio de Opciones (Venta) |
7,314 |
$149.62 |
$1.09M |
- |
| 2026-02-18 |
Saleki-gerhardt Azita |
EVP, Chief Operations Officer |
Concesión de RSU |
20,312 |
$230.04 |
$4.67M |
20,312 |
| 2026-02-18 |
Michael Robert A. |
Chief Executive Officer |
Concesión de RSU |
81,251 |
$230.04 |
$18.69M |
81,251 |
| 2026-02-18 |
Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
Concesión de RSU |
26,812 |
$230.04 |
$6.17M |
26,812 |
| 2026-02-18 |
Donoghoe Nicholas |
EVP, Chief Bus/strat Officer |
Concesión de RSU |
20,312 |
$230.04 |
$4.67M |
20,312 |
| 2026-02-18 |
Reents Scott T |
EVP, Chief Financial Officer |
Concesión de RSU |
21,937 |
$230.04 |
$5.05M |
21,937 |
| 2026-02-18 |
Siatis Perry C |
EVP, Gc and Secretary |
Concesión de RSU |
19,500 |
$230.04 |
$4.49M |
19,500 |
| 2026-02-18 |
Thakkar Roopal |
EVP, R&d and CSO |
Concesión de RSU |
21,937 |
$230.04 |
$5.05M |
21,937 |
| 2026-02-18 |
Purdue David Ryan |
SVP, Controller |
Concesión de RSU |
4,875 |
$230.04 |
$1.12M |
4,875 |
| 2026-02-18 |
Crum Demetris D |
EVP, Chief HR Officer |
Concesión de RSU |
1,216 |
- |
- |
8,264 |
| 2025-12-31 |
Rapp Edward J |
Director |
Concesión de RSU |
147 |
$228.49 |
$33.59K |
28,498 |
| 2025-12-31 |
Alpern Robert J |
Director |
Concesión de RSU |
34 |
$228.49 |
$7.77K |
10,257 |
| 2025-12-31 |
Quaggin Susan E |
Director |
Concesión de RSU |
68 |
$228.49 |
$15.54K |
707 |
| 2025-09-30 |
Rapp Edward J |
Director |
Concesión de RSU |
145 |
$231.54 |
$33.57K |
28,152 |
| 2025-09-30 |
Alpern Robert J |
Director |
Concesión de RSU |
33 |
$231.54 |
$7.64K |
10,151 |
| 2025-09-30 |
Quaggin Susan E |
Director |
Concesión de RSU |
67 |
$231.54 |
$15.51K |
634 |
| 2025-08-12 |
Saleki-gerhardt Azita |
EVP, Chief Operations Officer |
Ejercicio de Opciones (Venta) |
42,370 |
$54.86 |
$2.32M |
- |
| 2025-08-05 |
Donoghoe Nicholas |
EVP, Chief Bus/strat Officer |
Venta Informativa |
10,061 |
$198.59 |
$2M |
58,247 |
| 2025-07-01 |
Abbvie Inc. |
EVP, Chief HR Officer |
Desconocido |
4,687 |
$192.86 |
$903.93K |
- |
| 2025-07-01 |
Crum Demetris D |
EVP, Chief HR Officer |
Desconocido |
5,043 |
$175.28 |
$883.94K |
- |
| 2025-06-30 |
Rapp Edward J |
Director |
Concesión de RSU |
177 |
$185.62 |
$32.85K |
27,785 |
| 2025-06-30 |
Alpern Robert J |
Director |
Concesión de RSU |
40 |
$185.62 |
$7.42K |
10,038 |
| 2025-06-30 |
Quaggin Susan E |
Director |
Concesión de RSU |
81 |
$185.62 |
$15.04K |
562 |
| 2025-05-09 |
Austin Roxanne S |
Director |
Concesión de RSU |
1,203 |
- |
- |
38,458 |
| 2025-05-09 |
Rapp Edward J |
Director |
Concesión de RSU |
1,203 |
- |
- |
34,458 |
| 2025-05-09 |
Tilton Glenn F |
Director |
Concesión de RSU |
1,203 |
- |
- |
51,564 |
| 2025-05-09 |
Falk Thomas J |
Director |
Desconocido |
- |
- |
- |
1,203 |
| 2025-05-09 |
Falk Thomas J |
Director |
Concesión de RSU |
1,203 |
- |
- |
1,203 |
| 2025-05-09 |
Waddell Frederick H |
Director |
Concesión de RSU |
1,203 |
- |
- |
28,958 |
| 2025-05-09 |
Freyman Thomas C |
Director |
Concesión de RSU |
1,203 |
- |
- |
126,751 |
| 2025-05-09 |
Roberts Rebecca B |
Director |
Concesión de RSU |
1,203 |
- |
- |
13,728 |
| 2025-05-09 |
Alpern Robert J |
Director |
Concesión de RSU |
1,203 |
- |
- |
35,646 |
| 2025-05-09 |
Hart Brett J |
Director |
Concesión de RSU |
1,203 |
- |
- |
19,472 |
| 2025-05-09 |
Burnside William H.l. |
Director |
Concesión de RSU |
1,203 |
- |
- |
26,958 |
| 2025-05-09 |
Meyer Melody B |
Director |
Concesión de RSU |
1,203 |
- |
- |
16,498 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
